BELITE BIO INC - ADR (BLTE) Stock Cash Flow
NASDAQ:BLTE - Nasdaq - US07782B1044 - ADR - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -36.00M | -31.63M | -12.65M | -9.67M | -5.75M | |||
| Depreciation Amortization | 450.00K | 400.00K | 60.00K | 30.00K | 20.00K | |||
| Change In Working Capital | 1.13M | -2.43M | -490.00K | 640.00K | -70.00K | |||
| Interest Paid | 0.00 | 0.00 | 20.00K | 0.00 | 20.00K | |||
| Taxes Paid | 10.00K | 10.00K | 0.00 | N/A | N/A | |||
| Other non cash items | 5.33M | 3.82M | 1.62M | 1.52M | 1.36M | |||
| OPERATING CASH FLOW | -29.00M | -30.00M | -11.46M | -7.47M | -4.44M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -150.00K | -60.00K | -390.00K | -70.00K | 0.00 | |||
| Other Investing Activity | -110.00M | 0.00 | 0.00 | 20.00K | -20.00K | |||
| INVESTING CASH FLOW | -111.00M | -60.00K | -390.00K | -60.00K | -20.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 0.00 | -2.32M | |||
| Stock Issued/Repurchased | 42.00M | 22.00M | 37.99M | 230.00K | 30.38M | |||
| Other Financing Activity | 42.00M | 54.00M | -1.03M | -820.00K | 0.00 | |||
| FINANCING CASH FLOW | 84.00M | 76.00M | 36.96M | -580.00K | 28.06M | |||
| Exchange Rate Effect | -270.00K | 10.00K | -370.00K | -160.00K | 0.00 | |||
| CHANGE IN CASH | -56.27M | 45.95M | 24.74M | -8.27M | 23.60M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -29.00M | -30.00M | -11.46M | -7.47M | -4.44M | |||
| Capital Expenditure | -150.00K | -60.00K | -390.00K | -70.00K | 0.00 | |||
| FREE CASH FLOW | -29.15M | -30.06M | -11.85M | -7.54M | -4.44M | |||
All data in USD